(CA)
BAMLANIVIMAB(INNE)
BAMLANIVIMAB(INNF)
BAMLANIVIMAB(INND)
BAMLANIVIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-455) [VH (HOMO SAPIENS IGHV1-69*04 (99.0%) -(IGHD) -IGHJ6*01 (90.9%) T123>A (120)) CDR-IMGT [8.8.18] (26-33.51-58.97-114) (1-125) -HOMO SAPIENS IGHG1*03 (100%) G1M3, NG1M1 (CH1 R120 (222) (126-223), HINGE 1-15 (224-238), CH2 (239-348), CH3 E12 (364), M14 (366) (349-453), CHS (454-455)) (126- 454)], (228-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') [V-KAPPA (HOMO SAPIENS IGKV1- 39*01 (97.9%) -IGKJ1*01 (100%)) CDR-IMGT [6.3.9] (27-32.50-52.89-97) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (153), V101 (191) (108'-214')]; DIMER (234-234":237-237")-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO) CELL LINE DERIVED FROM CHO-K1SV, LACKING THE GLUTAMINE SYNTHETASE (GS) GENE, GLYCOFORM ALFA; PROPOSED INN LIST 124-COVID, REC. LIST 85(WHO)
IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL LY3819253 GAMMA1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3819253 KAPPA-CHAIN, DIMER(PCHC)
BAMLANIVIMABUM(INN)